menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Solanine-L...
source image

Bioengineer

6h

read

202

img
dot

Image Credit: Bioengineer

Solanine-Loaded NPs: A New BC Therapy

  • A recent study in BMC Cancer introduces solanine-loaded niosome nanoparticles (SN-NPs) as a promising approach to breast cancer treatment, leveraging solanine's anticancer properties.
  • Engineering SN-NPs addresses solanine's solubility issues and systemic toxicity at therapeutic doses by encapsulating it in biocompatible niosomes.
  • The SN-NPs, with an average size of 50-70 nanometers and high encapsulation efficiency exceeding 82%, exhibit controlled release kinetics optimized for anti-tumor efficacy.
  • Cytotoxicity evaluations against MCF-7 breast cancer cells demonstrate a significant enhancement in efficacy with SN-NPs compared to free solanine treatments.
  • Flow cytometry analyses reveal the induction of apoptosis and cell cycle arrest by SN-NPs, showing a promising preference for apoptotic pathways over necrosis.
  • Quantitative PCR analyses demonstrate upregulation of pro-apoptotic genes and downregulation of anti-apoptotic and metastasis-related genes upon SN-NP treatment.
  • The research underscores the importance of SN-NPs in enhancing solanine's therapeutic potential through targeted delivery, controlled release, and gene expression modulation.
  • Niosomes present a versatile nanocarrier platform that can be extended to encapsulate other hydrophobic agents, paving the way for broader applications in oncological nanomedicine.
  • The study's comprehensive validation through physicochemical characterization, cytotoxicity assays, and gene expression profiling supports the advancement of SN-NPs to preclinical and clinical testing phases.
  • This research signifies a transformative synergy between natural bioactive compounds and nanotechnology, offering a tailored and effective approach in breast cancer intervention.
  • By merging solanine's potency with nanotechnological sophistication, SN-NPs provide a promising avenue for more precise, less toxic, and targeted breast cancer therapies.

Read Full Article

like

12 Likes

For uninterrupted reading, download the app